FDAnews Drug Daily Bulletin

Novartis Drug for Smoker’s Cough Boosts Lung Function in Study

A A
Novartis’s experimental drug for smoker’s cough helped patients in a late-stage trial, and was at least as good as a treatment sold by Boehringer Ingelheim and Pfizer.
Businessweek